Xiaolan Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaolan Chen has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Nanfeng Zheng
New Cornerstone Science Laboratory State Key Laboratory for Physical Chemistry of Solid Surfaces Collaborative Innovation Center of Chemistry for Energy Materials and National & Local Joint Engineering Research Center of Preparation Technology of Nanomaterials College of Chemistry and Chemical Engineering Xiamen University Xiamen China
19 shared publications Jingchao Li
Department of Nuclear Medicine, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
12 shared publicationsXinyan Hu
Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China
11 shared publicationsZichen Ye
State Key Laboratory for Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials, National & Local Joint Engineering Research Center of Preparation Technology of Nanomaterials, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China
10 shared publicationsJingping Wei
State Key Laboratory for Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials, National & Local Joint Engineering Research Center of Preparation Technology of Nanomaterials, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China
9 shared publicationsDuo Sun
State Key Laboratory for Physical Chemistry of Solid Surfaces, Collaborative Innovation Center of Chemistry for Energy Materials and Engineering, Research Center for Nano-Preparation Technology of Fujian Province, College of Chemistry and Chemical Engineering , Xiamen University , Xiamen 361005 , China
7 shared publications
Latest Publications
- 2 July 2026
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 363 (Pt 2) , 128352
Os-Ce nanoparticles with specific enzyme-like activity for total antioxidant capacity detection in beverages and cosmetics
- 2 July 2026
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 363 (Pt 2) , 128352
Os-Ce nanoparticles with specific enzyme-like activity for total antioxidant capacity detection in beverages and cosmetics
- 13 November 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (44) , 25605-25615
Rationally engineered Pd–Os nanosheets eliminating reactive oxygen and nitrogen species for in situ nanocatalytic therapy of ear inflammation
Two-dimensional Pd–Os nanozymes with outstanding antioxidative properties were developed for cell protection and in situ nanocatalytic treatment of ear inflammation by eliminating reactive oxygen and nitrogen species.
- 13 November 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (44) , 25605-25615
Rationally engineered Pd–Os nanosheets eliminating reactive oxygen and nitrogen species for in situ nanocatalytic therapy of ear inflammation
Two-dimensional Pd–Os nanozymes with outstanding antioxidative properties were developed for cell protection and in situ nanocatalytic treatment of ear inflammation by eliminating reactive oxygen and nitrogen species.
- 4 July 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 319, 145792
RONS clearing TePt @ sodium carboxymethyl cellulose nanozymes for chronic enteritis therapy
- 4 July 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 319, 145792
RONS clearing TePt @ sodium carboxymethyl cellulose nanozymes for chronic enteritis therapy
- 27 June 2025
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 20 (18) , e00613
Ultrasmall Rh‐Mo Nanoparticles with Prominent Peroxidase Activity for Colorimetric Sensing of L‐Cysteine
Nanozymes with peroxidase‐mimicking properties have emerged as attractive candidates for diverse biomedical applications. In this study, we first prepared ultrasmall rhodium‐molybdenum nanoparticles (Rh‐Mo NPs) via a straightforward hydrothermal method, which exhibited remarkable peroxidase (POD)‐like catalytic activity. These nanoparticles effectively catalyzed the oxidation of colorless 3,3′,5,5′‐tetramethylbenzidine (TMB) in the presence of H₂O₂ to generate blue oxidized TMB (ox‐TMB), demonstrating superior catalytic performance and substrate specificity. Leveraging this exceptional enzymatic activity, we established a novel colorimetric biosensing platform for sensitive determination of L‐cysteine (L‐Cys). Experimental data confirmed dual linear absorbance‐concentration correlations for L‐Cys (0.01–10.0 µM, limit of detection (LOD) = 3.3 nM; 10.0–40.0 µM, LOD = 26.5 nM), exhibiting a segmented dose–response pattern over the 0.01–40.0 µM detection range. The sensing system has three significant advantages: (1) intuitive operation requiring minimal technical expertise, (2) accelerated analysis completion within 5 min, and (3) exceptional sensitivity with low LOD. Notably, the Rh‐Mo NPs‐based sensing platform could successfully detect endogenous L‐Cys in complex biological matrices, including serum and milk samples, confirming their practical applicability in real‐sample analysis
- 27 June 2025
- Published by Wiley in Chemistry – An Asian Journal
- Vol. 20 (18) , e00613
Ultrasmall Rh‐Mo Nanoparticles with Prominent Peroxidase Activity for Colorimetric Sensing of L‐Cysteine
Nanozymes with peroxidase‐mimicking properties have emerged as attractive candidates for diverse biomedical applications. In this study, we first prepared ultrasmall rhodium‐molybdenum nanoparticles (Rh‐Mo NPs) via a straightforward hydrothermal method, which exhibited remarkable peroxidase (POD)‐like catalytic activity. These nanoparticles effectively catalyzed the oxidation of colorless 3,3′,5,5′‐tetramethylbenzidine (TMB) in the presence of H₂O₂ to generate blue oxidized TMB (ox‐TMB), demonstrating superior catalytic performance and substrate specificity. Leveraging this exceptional enzymatic activity, we established a novel colorimetric biosensing platform for sensitive determination of L‐cysteine (L‐Cys). Experimental data confirmed dual linear absorbance‐concentration correlations for L‐Cys (0.01–10.0 µM, limit of detection (LOD) = 3.3 nM; 10.0–40.0 µM, LOD = 26.5 nM), exhibiting a segmented dose–response pattern over the 0.01–40.0 µM detection range. The sensing system has three significant advantages: (1) intuitive operation requiring minimal technical expertise, (2) accelerated analysis completion within 5 min, and (3) exceptional sensitivity with low LOD. Notably, the Rh‐Mo NPs‐based sensing platform could successfully detect endogenous L‐Cys in complex biological matrices, including serum and milk samples, confirming their practical applicability in real‐sample analysis
- 14 October 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (48) , 22312-22325
Cerium oxide-modified Pd nanosheets encapsulated by red blood cell membranes for high-efficiency RONS scavenging in depression treatment
Pd–CeO 2 @RBC nanozymes with outstanding antioxidative activities have been developed to penetrate the blood–brain barrier and alleviate lipopolysaccharide-induced depression symptoms by scavenging reactive oxygen and nitrogen species (RONS).
- 14 October 2024
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 16 (48) , 22312-22325
Cerium oxide-modified Pd nanosheets encapsulated by red blood cell membranes for high-efficiency RONS scavenging in depression treatment
Pd–CeO 2 @RBC nanozymes with outstanding antioxidative activities have been developed to penetrate the blood–brain barrier and alleviate lipopolysaccharide-induced depression symptoms by scavenging reactive oxygen and nitrogen species (RONS).
- 16 September 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 678 (Pt C) , 380-392
Exploration of uricase-like activity in Pd@Ir nanosheets and their application in relieving acute gout using self-cascade reaction
- 16 September 2024
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 678 (Pt C) , 380-392
Exploration of uricase-like activity in Pd@Ir nanosheets and their application in relieving acute gout using self-cascade reaction
- Open Access
- 13 September 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (39) , 16112-16117
Synthesis and crystallization of a carboxylate functionalized N -heterocyclic carbene-based Au 13 cluster with strong photo-luminescence
The synthesis and crystallization of a –COOH-capped N -heterocyclic carbene (NHC)-protected Au 13 cluster with high photoluminescence.
- 13 September 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (39) , 16112-16117
Open AccessSynthesis and crystallization of a carboxylate functionalized N -heterocyclic carbene-based Au 13 cluster with strong photo-luminescence
The synthesis and crystallization of a –COOH-capped N -heterocyclic carbene (NHC)-protected Au 13 cluster with high photoluminescence.
- Open Access
- 3 January 2024
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 22 (1) , 1-15
A continuously efficient O2-supplying strategy for long-term modulation of hypoxic tumor microenvironment to enhance long-acting radionuclides internal therapy
Radionuclides internal radiotherapy (RIT) is a clinically powerful method for cancer treatment, but still poses unsatisfactory therapeutic outcomes due to the hypoxic characteristic of tumor microenvironment (TME). Catalase (CAT) or CAT-like nanomaterials can be used to enzymatically decompose TME endogenous H2O2 to boost TME oxygenation and thus alleviate the hypoxic level within tumors, but their effectiveness is still hindered by the short-lasting of hypoxia relief owing to their poor stability or degradability, thereby failing to match the long therapeutic duration of RIT. Herein, we proposed an innovative strategy of using facet-dependent CAT-like Pd-based two-dimensional (2D) nanoplatforms to continuously enhance RIT. Specifically, rationally designed 2D Pd@Au nanosheets (NSs) enable consistent enzymatic conversion of endogenous H2O2 into O2 to overcome hypoxia-induced RIT resistance. Furthermore, partially coated Au layer afford NIR-II responsiveness and moderate photothermal treatment that augmenting their enzymatic functionality. This approach with dual-effect paves the way for reshaping TME and consequently facilitating the brachytherapy ablation of cancer. Our work offers a significant advancement in the integration of catalytic nanomedicine and nuclear medicine, with the overarching goal of amplifying the clinical benefits of RIT-treated patients. Graphical abstract
- 3 January 2024
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 22 (1) , 1-15
Open AccessA continuously efficient O2-supplying strategy for long-term modulation of hypoxic tumor microenvironment to enhance long-acting radionuclides internal therapy
Radionuclides internal radiotherapy (RIT) is a clinically powerful method for cancer treatment, but still poses unsatisfactory therapeutic outcomes due to the hypoxic characteristic of tumor microenvironment (TME). Catalase (CAT) or CAT-like nanomaterials can be used to enzymatically decompose TME endogenous H2O2 to boost TME oxygenation and thus alleviate the hypoxic level within tumors, but their effectiveness is still hindered by the short-lasting of hypoxia relief owing to their poor stability or degradability, thereby failing to match the long therapeutic duration of RIT. Herein, we proposed an innovative strategy of using facet-dependent CAT-like Pd-based two-dimensional (2D) nanoplatforms to continuously enhance RIT. Specifically, rationally designed 2D Pd@Au nanosheets (NSs) enable consistent enzymatic conversion of endogenous H2O2 into O2 to overcome hypoxia-induced RIT resistance. Furthermore, partially coated Au layer afford NIR-II responsiveness and moderate photothermal treatment that augmenting their enzymatic functionality. This approach with dual-effect paves the way for reshaping TME and consequently facilitating the brachytherapy ablation of cancer. Our work offers a significant advancement in the integration of catalytic nanomedicine and nuclear medicine, with the overarching goal of amplifying the clinical benefits of RIT-treated patients. Graphical abstract
- 23 June 2023
- Published by Tsinghua University Press in Nano Research
- Vol. 17 (1) , 270-281
Pd@Ir-LOD multienzyme utilizing endogenous lactate consumption cooperates with photothermal for tumor therapy
Lactic acid (LA) plays a major role in the occurrence, development, and spread of cancer. Enlightened by its high accumulation in tumor site, a novel lactate oxidase (LOD) conjugated two-dimensional Pd@Ir nanoplatform (Pd@Ir-LOD, PIL) was fabricated to combine cascade reaction with photothermal for tumor therapy. In detail, the overexpressed LA in tumor microenvironment (TME) was a key factor to activate the PIL-based cascade reaction: (1) Plenty of H2O2 could be generated from LA by the catalysis of LOD with O2; (2) potent OH was produced from H2O2 due to the peroxidase (POD)-like activity of PIL; (3) meantime, PIL’s catalase (CAT)-like activity could decompose part H2O2 into O2 to achieve the purpose of LA cyclic oxidization. Moreover, the reduced glutathione (GSH) scavenging capability of PIL might protect the produced reactive oxygen species (ROS) from being cleared to further improve the cascade therapeutic effect. More importantly, PIL had excellent photothermal conversion efficiency (37.35%) and manifested a surprising temperature rising effect in tumor. Taken together, the decreasing LA concentration, accumulation of high-toxic ROS, the depletion of GSH together with the higher intra-tumoral temperature potently enhanced in vivo antitumor therapy. Therefore, a promising therapeutic tactic based on PIL integrating endogenous LA consumption, chemodynamic therapy (CDT), and photothermal therapy (PTT) has been put forward.
- 23 June 2023
- Published by Tsinghua University Press in Nano Research
- Vol. 17 (1) , 270-281
Pd@Ir-LOD multienzyme utilizing endogenous lactate consumption cooperates with photothermal for tumor therapy
Lactic acid (LA) plays a major role in the occurrence, development, and spread of cancer. Enlightened by its high accumulation in tumor site, a novel lactate oxidase (LOD) conjugated two-dimensional Pd@Ir nanoplatform (Pd@Ir-LOD, PIL) was fabricated to combine cascade reaction with photothermal for tumor therapy. In detail, the overexpressed LA in tumor microenvironment (TME) was a key factor to activate the PIL-based cascade reaction: (1) Plenty of H2O2 could be generated from LA by the catalysis of LOD with O2; (2) potent OH was produced from H2O2 due to the peroxidase (POD)-like activity of PIL; (3) meantime, PIL’s catalase (CAT)-like activity could decompose part H2O2 into O2 to achieve the purpose of LA cyclic oxidization. Moreover, the reduced glutathione (GSH) scavenging capability of PIL might protect the produced reactive oxygen species (ROS) from being cleared to further improve the cascade therapeutic effect. More importantly, PIL had excellent photothermal conversion efficiency (37.35%) and manifested a surprising temperature rising effect in tumor. Taken together, the decreasing LA concentration, accumulation of high-toxic ROS, the depletion of GSH together with the higher intra-tumoral temperature potently enhanced in vivo antitumor therapy. Therefore, a promising therapeutic tactic based on PIL integrating endogenous LA consumption, chemodynamic therapy (CDT), and photothermal therapy (PTT) has been put forward.